Active, not recruitingPhase 2NCT05291091
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Studying Becker muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Edgewise Therapeutics, Inc.
- Principal Investigator
- Joanne Donovan, MD, PhDEdgewise Therapeutics, Inc.
- Intervention
- Sevasemten 10 mg(drug)
- Enrollment
- 244 enrolled
- Eligibility
- 12-50 years · MALE
- Timeline
- 2022 – 2026
Study locations (30)
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- UC San Diego, La Jolla, California, United States
- UCLA Medical Center, Los Angeles, California, United States
- UC Irvine Medical Center, Orange, California, United States
- Stanford Neuroscience Health Center, Palo Alto, California, United States
- UC Davis Medical Center, Sacramento, California, United States
- UC Denver, Aurora, Colorado, United States
- University of Florida, Gainesville, Florida, United States
- Rare Disease Research, Atlanta, Georgia, United States
- Northwestern University, Chicago, Illinois, United States
- Indiana University School of Medicine, Indianapolis, Indiana, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Kennedy Krieger Institute, Baltimore, Maryland, United States
- University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Medpace, Inc. · ImagingNMD · SYSNAV
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05291091 on ClinicalTrials.govOther trials for Becker muscular dystrophy
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07565272Usability and User Experience of a Virtual Reality Rehabilitation Game Platform in Individuals With Duchenne Muscular DystrophyIstanbul University
- ENROLLING BY INVITATIONNANCT07543302Can External Vagus Nerve Stimulation Reduce Systemic Levels of Inflammatory Mediators in Duchenne Muscular Dystrophy Patients?taVNS AB
- RECRUITINGNCT07515235DMD Gene Variants and Cardiac Dysfunction in Young Males With DystrophinopathiesAristotle University Of Thessaloniki
- RECRUITINGNANCT07415421Parathyroidectomy After Kidney TransplantationAarhus University Hospital
- ACTIVE NOT RECRUITINGNCT07519720An Assessment of Risk Factors for Osteosarcopenia in Older Adults - the Role of Prevention, Lifestyle, Physical Activity and Education.Wroclaw University of Health and Sport Sciences
- ENROLLING BY INVITATIONPHASE1NCT07178327Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101Shanghai TTM-Bio Technology Co., Ltd
- RECRUITINGNCT07565051Can Pre-operative Lean Mass Predict Weight Loss After Roux-en-Y Gastric Bypass?University Hospital, Geneva
- RECRUITINGNANCT06949280Metabolic Health, Bones and Nuts During Weight Loss in AdultsRutgers, The State University of New Jersey